You are here

Association of a blood-based aging biomarker index with death and chronic disease: Cardiovascular Health Study.

TitleAssociation of a blood-based aging biomarker index with death and chronic disease: Cardiovascular Health Study.
Publication TypeJournal Article
Year of Publication2023
AuthorsZhang, X, Sanders, JL, Boudreau, RM, Arnold, AM, Justice, JN, Espeland, MA, Kuchel, GA, Barzilai, N, Kuller, LH, Lopez, OL, Kritchevsky, SB, Newman, AB
JournalJ Gerontol A Biol Sci Med Sci
Date Published2023 Jul 19
ISSN1758-535X
Abstract<p><b>BACKGROUND: </b>A goal of gerontology is to discover phenotypes that reflect biological aging distinct from disease pathogenesis. Biomarkers that are strongly associated with mortality could be used to define such a phenotype. However, the relation of such an index with multiple chronic conditions warrants further exploration.</p><p><b>METHODS: </b>A Biomarker Index (BI) was constructed in the Cardiovascular Health Study (N=3197), with a mean age of 74 years. The BI incorporated circulating levels of new biomarkers, including insulin-like growth factor-1, interleukin-6, amino-terminal pro-B-type natriuretic peptide, cystatin-C, C-reactive protein, tumor necrosis factor-alpha soluble receptor 1, fasting insulin, and fasting glucose, and was built based on their relationships with mortality. Cox proportional hazards models predicting a composite of death and chronic disease involving cardiovascular disease, dementia, and cancer were calculated with 6 years of follow-up.</p><p><b>RESULTS: </b>The hazard ratio (HR, 95% CI) for the composite outcome of death or chronic disease per category of BI was 1.65 (1.52, 1.80) and 1.75 (1.58, 1.94) in women and men, respectively. The HR (95% CI) per 5 years of age was 1.57 (1.48, 1.67) and 1.55 (1.44, 1.67) in women and men, respectively. Moreover, BI could attenuate the effect of age on the composite outcome by 16.7% and 22.0% in women and men, respectively.</p><p><b>CONCLUSIONS: </b>BI was significantly and independently associated with a composite outcome of death and chronic disease, and attenuated the effect of age. The BI that is composed of plasma biomarkers may be a practical intermediate phenotype for interventions aiming to modify the course of aging.</p>
DOI10.1093/gerona/glad172
Alternate JournalJ Gerontol A Biol Sci Med Sci
PubMed ID37464278
ePub date: 
23/07